Cargando…
Serum Cytokine Concentrations in a Patient with Rheumatoid Arthritis on Etanercept Therapy Who Subsequently Developed Pneumocystis Pneumonia: A Case Report
We report a rheumatoid arthritis patient who was treated with etanercept. Serum levels of tumor-necrosis-factor- (TNF-) alpha, soluble-tumor-necrosis-factor receptor- (sTNFR-) I and -II, interleukin- (IL-) 6, and IL-1 beta were measured by ELISA before and during the course of therapy. While the ser...
Autores principales: | Sato, Masao, Takemura, Masao, Shinohe, Ryuki, Shimizu, Katsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420776/ https://www.ncbi.nlm.nih.gov/pubmed/22937439 http://dx.doi.org/10.1155/2011/185657 |
Ejemplares similares
-
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
por: Katsuyama, Takayuki, et al.
Publicado: (2014) -
Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007) -
Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000) -
Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2007) -
Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient
por: Shobayo, Anuoluwapo, et al.
Publicado: (2019)